Cargando…
Gender Trends in Psychotropic Medication Use in Autism
Autism is a neurodevelopmental condition that includes differences in social communication and restrictive, repetitive behavior. Its diagnosis is far more common in men than women. Therefore, a female phenotype of autism might not concern caregivers or be detected early by clinical assessments. Give...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245521/ https://www.ncbi.nlm.nih.gov/pubmed/35800200 http://dx.doi.org/10.7759/cureus.26447 |
_version_ | 1784738756736057344 |
---|---|
author | Huber, Christopher R Fanaro, Zachary Soti, Varun |
author_facet | Huber, Christopher R Fanaro, Zachary Soti, Varun |
author_sort | Huber, Christopher R |
collection | PubMed |
description | Autism is a neurodevelopmental condition that includes differences in social communication and restrictive, repetitive behavior. Its diagnosis is far more common in men than women. Therefore, a female phenotype of autism might not concern caregivers or be detected early by clinical assessments. Given that medications address problematic behaviors rather than autism, different problems associated with autism necessitate other treatments. We reviewed existing literature on gender differences in psychotropic drug usage in autism patients and found that antidepressants, anticonvulsants, and mood stabilizers were more common in females, while stimulants and antipsychotics were predominant in males. This review highlights that autistic men and women receive different pharmacologic agents, likely attributable to gender-specific trends in presenting problematic behaviors. |
format | Online Article Text |
id | pubmed-9245521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-92455212022-07-06 Gender Trends in Psychotropic Medication Use in Autism Huber, Christopher R Fanaro, Zachary Soti, Varun Cureus Neurology Autism is a neurodevelopmental condition that includes differences in social communication and restrictive, repetitive behavior. Its diagnosis is far more common in men than women. Therefore, a female phenotype of autism might not concern caregivers or be detected early by clinical assessments. Given that medications address problematic behaviors rather than autism, different problems associated with autism necessitate other treatments. We reviewed existing literature on gender differences in psychotropic drug usage in autism patients and found that antidepressants, anticonvulsants, and mood stabilizers were more common in females, while stimulants and antipsychotics were predominant in males. This review highlights that autistic men and women receive different pharmacologic agents, likely attributable to gender-specific trends in presenting problematic behaviors. Cureus 2022-06-30 /pmc/articles/PMC9245521/ /pubmed/35800200 http://dx.doi.org/10.7759/cureus.26447 Text en Copyright © 2022, Huber et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Neurology Huber, Christopher R Fanaro, Zachary Soti, Varun Gender Trends in Psychotropic Medication Use in Autism |
title | Gender Trends in Psychotropic Medication Use in Autism |
title_full | Gender Trends in Psychotropic Medication Use in Autism |
title_fullStr | Gender Trends in Psychotropic Medication Use in Autism |
title_full_unstemmed | Gender Trends in Psychotropic Medication Use in Autism |
title_short | Gender Trends in Psychotropic Medication Use in Autism |
title_sort | gender trends in psychotropic medication use in autism |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245521/ https://www.ncbi.nlm.nih.gov/pubmed/35800200 http://dx.doi.org/10.7759/cureus.26447 |
work_keys_str_mv | AT huberchristopherr gendertrendsinpsychotropicmedicationuseinautism AT fanarozachary gendertrendsinpsychotropicmedicationuseinautism AT sotivarun gendertrendsinpsychotropicmedicationuseinautism |